PNPLA3 rs738409基因多态性对非酒精性脂肪性肝病患者肝脏相关事件发生的影响
回顾性分析意大利、英国和西班牙756例经活检证实的非酒精性脂肪性肝病患者,中位随访84个月。PNPLA3 rs738409 GG风险基因型在女性(31.5% vs 22.3%,P=.006)和非肥胖者(50.0% vs 44.2%,P=.011)中更常见;年龄>50岁的非肥胖女性携带GG基因型者肝脏相关事件发生率增高(log-rank检验,P=.0047)。
要点
- PNPLA3 rs738409 GG基因型在女性中更常见(31.5% vs 22.3%,P=.006)。
- GG基因型在非肥胖者中更常见(50.0% vs 44.2%,P=.011)。
- 年龄>50岁非肥胖女性携带GG基因型者肝脏相关事件发生率增高(P=.0047)。
核心结论
- 年龄50岁及以上、携带PNPLA3 GG风险基因型的非肥胖女性非酒精性脂肪性肝病患者,相比携带野生型等位基因(CC/CG)者,发生肝脏相关事件的风险更高。
研究设计与样本
- 回顾性分析756例来自意大利、英国和西班牙的连续、前瞻性入组的经活检证实的非酒精性脂肪性肝病患者,中位随访84个月(四分位距65-109个月)。
主要发现
- 中位年龄48岁,男性占64.7%。
- PNPLA3 rs738409基因型分布:CC型235例(31.1%),CG型328例(43.4%),GG型193例(25.5%)。
- 单因素分析中,PNPLA3 GG风险基因型与女性性别相关(比值比1.6,95%CI 1.1-2.2,P=.006),与BMI呈负相关(比值比0.97,95%CI 0.94-0.99,P=.043)。
- GG风险纯合子在女性中比男性更常见(31.5% vs 22.3%,P=.006),在非肥胖者中比肥胖者更常见(50.0% vs 44.2%,P=.011)。
- 按年龄、性别和BMI分层后,年龄大于50岁的非肥胖女性携带PNPLA3 GG风险基因型者肝脏相关事件发生率增高(log-rank检验,P=.0047)。
临床怎么用
- 作者认为该发现可能对临床实践中的风险分层和个体化医疗有启示。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Nonalcoholic fatty liver disease (NAFLD) is a complex disease, resulting from the interplay between environmental determinants and genetic variations. Single nucleotide polymorphism rs738409 C>G in the PNPLA3 gene is associated with hepatic fibrosis and with higher risk of developing hepatocellular carcinoma. Here, we analyzed a longitudinal cohort of biopsy-proven NAFLD subjects with the aim to identify individuals in whom genetics may have a stronger impact on disease progression. METHODS: We retrospectively analyzed 756 consecutive, prospectively enrolled biopsy-proven NAFLD subjects from Italy, United Kingdom, and Spain who were followed for a median of 84 months (interquartile range, 65-109 months). We stratified the study cohort according to sex, body mass index (BMI) </≥30 kg/m2) and age (</≥50 years). Liver-related events (hepatic decompensation, hepatic encephalopathy, esophageal variceal bleeding, and hepatocellular carcinoma) were recorded during the follow-up and the log-rank test was used to compare groups. RESULTS: Overall, the median age was 48 years and most individuals were men (64.7%). The PNPLA3 rs738409 genotype was CC in 235 (31.1%), CG in 328 (43.4%), and GG in 193 (25.5%) patients. At univariate analysis, the PNPLA3 GG risk genotype was associated with female sex and inversely related to BMI (odds ratio, 1.6; 95% confidence interval, 1.1-2.2; P = .006; and odds ratio, 0.97; 95% confidence interval, 0.94-0.99; P = .043, respectively). Specifically, PNPLA3 GG risk homozygosis was more prevalent in female vs male individuals (31.5% vs 22.3%; P = .006) and in nonobese compared with obese NAFLD subjects (50.0% vs 44.2%; P = .011). Following stratification for age, sex, and BMI, we observed an increased incidence of liver-related events in the subgroup of nonobese women older than 50 years of age carrying the PNPLA3 GG risk genotype (log-rank test, P = .0047). CONCLUSIONS: Nonobese female patients with NAFLD 50 years of age and older, and carrying the PNPLA3 GG risk genotype, are at higher risk of developing liver-related events compared with those with the wild-type allele (CC/CG). This finding may have implications in clinical practice for risk stratification and personalized medicine.
引用
- Rosso C, Caviglia GP, Birolo G, et al. Impact of PNPLA3 rs738409 Polymorphism on the Development of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2023. PMID: 37149016. doi:10.1016/j.cgh.2023.04.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。